Atsena Therapeutics Announces Positive 12-Month Safety and Efficacy Data From Ongoing Phase I/II Clinical Trial To Treat Leber Congenital Amaurosis
Atsena Therapeutics announced positive results in their 12-month safety and efficacy data from the ongoing Phase I/II trial of ATSN-101, the company’s investigational gene therapy for the treatment of GUCY2D-associated Leber congenital amaurosis (LCA1). At 12 months post-treatment, ATSN-101 has conferred clinically meaningful improvements in vision at the highest dose with no serious treatment-emergent adverse events.
Tech Tuesday – Adam Veige
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Adam Veige, professor in the UF Department of Chemistry and winner of an Invention of the Year award at StandingInnOvation 2023. He explains his invention, a cyclic version of polypropylene, which he aims to commercialize.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
Tech Tuesday – Cherie Stabler
In this week's Tech Tuesday for WCJB TV20, UF Innovate's Melanie Morón interviews Cherie Stabler, researcher and professor in the UF Department of Biomedical Engineering, who is conducting research on a possible cure for type 1 diabetes.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
Medical AI Tool From UF, Nvidia Gets Human Thumbs-Up in First Study
Researchers from the University of Florida and Nvidia have created an AI computer program that can generate accurate doctors' notes, opening the door for AI to support health care workers with groundbreaking efficiencies.
Tech Tuesday – Tyler Loftus
On this Tech Tuesday segment, Melanie Morón interviews Tyler Loftus, a trauma surgeon in the UF Department of Surgery whose research focuses on improving patient care in ICU setting using AI.
Budding Brainiacs: New Fellowship Program at the McKnight Brain Institute Offers Mentorship From Leading Neuroscientists
The UF McKnight Brain Institute's competitive new fellowship program, Gator NeuroScholars, aims to boost the University's research capabilities to solve the worlds's most complex diseases. The program provides post-docs from a wide variety of backgrounds with mentorship from some of the world's leading neuroscientists, driving discovery and innovation across the University.
